More than 30 types of muscular dystrophy have been identified. They all cause problems with movement due to muscle protein defects caused by genetic mutations. Muscular dystrophy is a group of ...
The FDA has granted breakthrough therapy designation to INCA033989 for some patients with essential thrombocythemia.
Hemophilia A is caused by a shortage of clotting factor VIII, while Hemophilia B results from a deficiency in clotting factor IX. Both types are inherited, and their severity may differ. Acquired ...